Invictus MD Strategies Kapitalrendite
Was ist das Kapitalrendite von Invictus MD Strategies?
Kapitalrendite von Invictus MD Strategies Corp. ist -31.74%
Was ist die Definition von Kapitalrendite?
Die Eigenkapitalrendite ist ein Maß für die Rentabilität eines Unternehmens im Verhältnis zum Buchwert des Eigenkapitals. Sie wird berechnet, indem das Nettoergebnis des Geschäftsjahres durch das gesamte Eigenkapital geteilt wird.
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Kapitalrendite von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Invictus MD Strategies
Was macht Invictus MD Strategies?
Invictus MD Strategies Corp. invests in, acquires, and develops synergistic businesses in the cannabis industry in Canada. The company operates through two segments, Sale of Cannabis and Fertilizers. It produces and sells medical cannabis; and plant fertilizers, nutrients, and other supplies for hydroponics, as well as operates medical clinics in Alberta. The company was incorporated in 2014 and is headquartered in Vancouver, Canada.
Unternehmen mit kapitalrendite ähnlich Invictus MD Strategies
- Technicolor SA hat Kapitalrendite von -31.76%
- Hyve Plc hat Kapitalrendite von -31.76%
- Hyve Plc hat Kapitalrendite von -31.76%
- Hyve Plc hat Kapitalrendite von -31.76%
- OSRAM Licht AG hat Kapitalrendite von -31.75%
- Yunhong International hat Kapitalrendite von -31.74%
- Invictus MD Strategies hat Kapitalrendite von -31.74%
- Westport Fuel Systems hat Kapitalrendite von -31.72%
- Most Kwai Chung hat Kapitalrendite von -31.71%
- Allergy Therapeutics plc hat Kapitalrendite von -31.69%
- Asian Hotels (West) hat Kapitalrendite von -31.69%
- Empress Royalty hat Kapitalrendite von -31.68%
- Perpetual Income & Growth Investment Trust Plc hat Kapitalrendite von -31.65%